IDEXX Laboratories Inc logo

IDEXX Laboratories Inc

8
1
NAS:IDXX (USA)   Ordinary Shares
$ 499.30 +10.06 (+2.06%) 10:08 PM EST
49.58
P/B:
27.93
Market Cap:
$ 41.47B
Enterprise V:
$ 42.08B
Volume:
529.80K
Avg Vol (2M):
410.56K
Also Trade In:
Volume:
529.80K
Avg Vol (2M):
410.56K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for IDEXX Laboratories Inc ( ) from 1991 to Apr 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. IDEXX Laboratories stock (IDXX) PE ratio as of Apr 28 2024 is 49.58. More Details

IDEXX Laboratories Inc (IDXX) PE Ratio (TTM) Chart

To

IDEXX Laboratories Inc (IDXX) PE Ratio (TTM) Historical Data

Total 1217
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
IDEXX Laboratories PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-28 49.6 2024-02-23 57.2
2024-04-26 49.6 2024-02-22 56.7
2024-04-25 48.6 2024-02-21 55.1
2024-04-24 49.1 2024-02-20 54.7
2024-04-23 49.0 2024-02-16 55.2
2024-04-22 47.6 2024-02-15 56.5
2024-04-19 47.3 2024-02-14 55.7
2024-04-18 47.5 2024-02-13 55.2
2024-04-17 47.5 2024-02-12 56.2
2024-04-16 48.6 2024-02-09 56.8
2024-04-15 48.8 2024-02-08 57.0
2024-04-12 49.4 2024-02-07 56.8
2024-04-11 50.0 2024-02-06 56.3
2024-04-10 50.1 2024-02-05 56.8
2024-04-09 51.6 2024-02-02 52.4
2024-04-08 51.1 2024-02-01 52.4
2024-04-05 51.6 2024-01-31 51.1
2024-04-04 51.5 2024-01-30 51.7
2024-04-03 52.0 2024-01-29 52.8
2024-04-02 51.8 2024-01-26 52.1
2024-04-01 52.9 2024-01-25 51.9
2024-03-28 53.6 2024-01-24 51.7
2024-03-27 53.6 2024-01-23 52.8
2024-03-26 52.7 2024-01-22 52.8
2024-03-25 52.6 2024-01-19 52.0
2024-03-22 52.7 2024-01-18 52.2
2024-03-21 52.8 2024-01-17 51.2
2024-03-20 52.6 2024-01-16 51.6
2024-03-19 53.1 2024-01-12 53.2
2024-03-18 52.6 2024-01-11 55.5
2024-03-15 52.6 2024-01-10 55.0
2024-03-14 53.2 2024-01-09 54.9
2024-03-13 53.6 2024-01-08 54.0
2024-03-12 54.3 2024-01-05 53.4
2024-03-11 54.5 2024-01-04 53.5
2024-03-08 55.8 2024-01-03 53.1
2024-03-07 55.9 2024-01-02 54.4
2024-03-06 55.4 2023-12-29 55.1
2024-03-05 55.4 2023-12-28 55.3
2024-03-04 56.7 2023-12-27 56.9
2024-03-01 57.3 2023-12-26 56.7
2024-02-29 57.1 2023-12-22 56.5
2024-02-28 56.8 2023-12-21 56.4
2024-02-27 57.1 2023-12-20 55.1
2024-02-26 56.6 2023-12-19 55.7

IDEXX Laboratories Inc (IDXX) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

IDEXX Laboratories Inc logo
IDEXX Laboratories Inc
NAICS : 325412 SIC : 2835
ISIN : US45168D1046

Share Class Description:

IDXX: Ordinary Shares
Description
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.